← Back to Clinical Trials
Recruiting NCT06531590

NCT06531590 Anterior Shoulder Dislocation at Emergency Department

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06531590
Status Recruiting
Phase
Sponsor Saglik Bilimleri Universitesi
Condition Shoulder Dislocation
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2024-03-01
Primary Completion 2026-03-01

Trial Parameters

Condition Shoulder Dislocation
Sponsor Saglik Bilimleri Universitesi
Study Type OBSERVATIONAL
Phase N/A
Enrollment 140
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-03-01
Completion 2026-03-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this study, investigator will analyze the demographic characteristics of patients presenting to emergency department with Anterior Shoulder Dislocation. Investigators will document the mechanism of injury, orthopedic classification of shoulder dislocation, associated treatments, pre-procedural pain scoring, post-procedural pain scoring, as well as the duration of emergency department stay related to the preferred treatment, orthopedic consultation, and patient outcomes (discharge, admission to ward or intensive care unit, mortality). Aim of the study to investigate whether the current treatments used provide any superiority in emergency department outcomes for patients

Eligibility Criteria

Inclusion Criteria: Patients aged 18 years and older Exclusion Criteria: Patients who are not conscious at the time of admission and do not consent to participate in the study. Patients who do not have follow-up in our healthcare system or cannot be followed up. Patients with allergies to opioids or local anesthetics. Patients presenting to the emergency department with suspicion of multiple fractures and dislocations involving ≥2 different types of injuries will also be excluded from the study. Forensic cases

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology